CS logo
small CS logo
Faculty of Medicine, Chiang Mai University

Chiang Mai, Thailand
โรงเรียนการแพทย์ในเทศบาลนครเชียงใหม่

About Faculty of Medicine, Chiang Mai University


คณะแพทยศาสตร์ มหาวิทยาลัยเชียงใหม่ เป็นโรงเรียนแพทย์แห่งที่ 3 ของประเทศไทยต่อจากคณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล และคณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย และยังเป็นเป็นโรงเรียนแพทย์ในส่วนภูมิภาคแห่งแรกของประเทศไทย และได้รับการรับรองจากแพทยสภาและเป็นแห่งที่ 3 ของประเทศถัดจากคณะแพทยศาสตร์ศิริราชพยาบาล ...
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Faculty of Medicine, Chiang Mai University


During the past decade, Faculty of Medicine, Chiang Mai University conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Faculty of Medicine, Chiang Mai University" #1 sponsor was "Chiang Mai University" with 8 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Mahidol University" with 2 trials sponsored and "Chulalongkorn University" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Faculty of Medicine, Chiang Mai University" #1 collaborator was "National Research Council of Thailand" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Clinixir Co., Ltd." with 1 trials as a collaborator, "Fondazione Angelo Bianchi Bonomi" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at Faculty of Medicine, Chiang Mai University


According to Clinical.Site data, the most researched conditions in "Faculty of Medicine, Chiang Mai University" are "Acute Kidney Injury" (2 trials), "HIV" (2 trials), "HIV Infections" (2 trials), "Hepatitis B, Chronic" (2 trials) and "Paralytic Ileus" (2 trials). Many other conditions were trialed in "Faculty of Medicine, Chiang Mai University" in a lesser frequency.

Clinical Trials Intervention Types at Faculty of Medicine, Chiang Mai University


Most popular intervention types in "Faculty of Medicine, Chiang Mai University" are "Drug" (15 trials), "Behavioral" (2 trials), "Dietary Supplement" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "ATV" (2 trials), "COBI" (2 trials), "FTC/TDF" (2 trials) and "Gum chewing" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Faculty of Medicine, Chiang Mai University


The vast majority of trials in "Faculty of Medicine, Chiang Mai University" are 22 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Faculty of Medicine, Chiang Mai University


Currently, there are NaN active trials in "Faculty of Medicine, Chiang Mai University". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Faculty of Medicine, Chiang Mai University, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Faculty of Medicine, Chiang Mai University, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".